{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:43:14Z","timestamp":1789076594421,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03429-y","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T08:11:09Z","timestamp":1728547869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biliary drainage in palliative and curative intent European patients with hilar cholangiocarcinoma and malignant hilar obstruction: a retrospective single center analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jan","family":"Drews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea-Catharina","family":"Baar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Schmeisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Bunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Caroline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J\u00fcrgen","family":"Oldhafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"von Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"3429_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755\u201362. https:\/\/doi.org\/10.1097\/01.sla.0000251366.62632.d3.","journal-title":"Ann Surg"},{"key":"3429_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma Lancet. 2005;366:1303\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(05)67530-7.","journal-title":"Cholangiocarcinoma Lancet"},{"key":"3429_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/hpb.12450","volume":"17","author":"JC Mansour","year":"2015","unstructured":"Mansour JC, Aloia TA, Crane CH, et al. Hilar Cholangiocarcinoma: Expert consensus statement. HPB. 2015;17:691\u20139. https:\/\/doi.org\/10.1111\/hpb.12450.","journal-title":"HPB"},{"key":"3429_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20:663\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X.","journal-title":"Lancet Oncol"},{"key":"3429_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/17474124.2021.1890031","volume":"15","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Brandi G. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Expert Rev Gastroenterol Hepatol. 2021;15:547\u201354. https:\/\/doi.org\/10.1080\/17474124.2021.1890031.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3429_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.gie.2020.12.035","volume":"94","author":"BJ Qumseya","year":"2021","unstructured":"Qumseya BJ, Jamil LH, Elmunzer BJ, et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest Endosc. 2021;94:222\u2013e23422. https:\/\/doi.org\/10.1016\/j.gie.2020.12.035.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1055\/a-0659-9864","volume":"50","author":"JM Dumonceau","year":"2018","unstructured":"Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - updated October 2017. Endoscopy. 2018;50:910\u201330.","journal-title":"Endoscopy"},{"key":"3429_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12957-020-01848-1","volume":"18","author":"W Zhang","year":"2020","unstructured":"Zhang W, Che X. Comparison of effect between nasobiliary drainage and biliary stenting in malignant biliary obstruction: a systematic review and updated meta-analysis. World J Surg Oncol. 2020;18:71. https:\/\/doi.org\/10.1186\/s12957-020-01848-1.","journal-title":"World J Surg Oncol"},{"key":"3429_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.21873\/invivo.11964","volume":"34","author":"A Rizzo","year":"2020","unstructured":"Rizzo A, Ricci AD, Frega G, et al. How to choose between Percutaneous Transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: an updated systematic review and Meta-analysis. Vivo. 2020;34:1701\u201314. https:\/\/doi.org\/10.21873\/invivo.11964.","journal-title":"Vivo"},{"key":"3429_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127\u201340. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.506.","journal-title":"Ann Oncol"},{"key":"3429_CR11","unstructured":"Deutsche Gesellschaft f\u00fcr Gastroenterologie VS e. V (DGVS). Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome Langversion 3.0, 2022, AWMF-Registernummer: 032\/053OL, https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/hcc-und-biliaere-karzinome\/; Retrieved 10\/03\/2023. 2022."},{"key":"3429_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","volume":"25","author":"S Kiriyama","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17\u201330. https:\/\/doi.org\/10.1002\/jhbp.512.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3429_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.gie.2021.11.038","volume":"95","author":"KJ Nass","year":"2022","unstructured":"Nass KJ, Zwager LW, van der Vlugt M, et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc. 2022;95:1078\u2013e10858. https:\/\/doi.org\/10.1016\/j.gie.2021.11.038.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/bjs.8950","volume":"100","author":"O Farges","year":"2013","unstructured":"Farges O, Regimbeau JM, Fuks D, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100:274\u201383. https:\/\/doi.org\/10.1002\/bjs.8950.","journal-title":"Br J Surg"},{"key":"3429_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.gie.2019.12.023","volume":"91","author":"MX Xia","year":"2020","unstructured":"Xia MX, Cai XB, Pan YL, et al. Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study. Gastrointest Endosc. 2020;91:1117\u2013e11289. https:\/\/doi.org\/10.1016\/j.gie.2019.12.023.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR16","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2000.18.14.2780","volume":"18","author":"AP Venook","year":"2000","unstructured":"Venook AP, Egorin MJ, Rosner GL, et al. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol. 2000;18:2780\u20137. https:\/\/doi.org\/10.1200\/JCO.2000.18.14.2780.","journal-title":"J Clin Oncol"},{"key":"3429_CR17","doi-asserted-by":"publisher","unstructured":"Oh D-Y, Ruth He A, Qin S, et al. Durvalumab plus Gemcitabine and Cisplatin in Advanced biliary tract Cancer. NEJM Evid. 2022;1. https:\/\/doi.org\/10.1056\/EVIDoa2200015.","DOI":"10.1056\/EVIDoa2200015"},{"key":"3429_CR18","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.2147\/CMAR.S308833","volume":"13","author":"X-Y Liang","year":"2021","unstructured":"Liang X-Y, Li W, Liu F, et al. A retrospective study of biliary drainage strategies for patients with malignant hilar biliary strictures. Cancer Manag Res. 2021;13:4767\u201376. https:\/\/doi.org\/10.2147\/CMAR.S308833.","journal-title":"Cancer Manag Res"},{"key":"3429_CR19","doi-asserted-by":"publisher","unstructured":"Liberato MJA, Canena JMT. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12. https:\/\/doi.org\/10.1186\/1471-230X-12-103.","DOI":"10.1186\/1471-230X-12-103"},{"key":"3429_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gie.2012.02.048","volume":"76","author":"A Sangchan","year":"2012","unstructured":"Sangchan A, Kongkasame W, Pugkhem A, et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc. 2012;76:93\u20139. https:\/\/doi.org\/10.1016\/j.gie.2012.02.048.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/den.13680","volume":"33","author":"MX Xia","year":"2021","unstructured":"Xia MX, Pan YL, Cai XB, et al. Comparison of endoscopic bilateral metal stent drainage with plastic stents in the palliation of unresectable hilar biliary malignant strictures: large multicenter study. Dig Endoscopy. 2021;33:179\u201389. https:\/\/doi.org\/10.1111\/den.13680.","journal-title":"Dig Endoscopy"},{"key":"3429_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.5009\/gnl20257","volume":"15","author":"JY Kim","year":"2021","unstructured":"Kim JY, Lee SG, Kang D, et al. The comparison of endoscopic biliary drainage in malignant hilar obstruction by cholangiocarcinoma: bilateral metal stents versus multiple plastic stents. Gut Liver. 2021;15:922\u20139. https:\/\/doi.org\/10.5009\/gnl20257.","journal-title":"Gut Liver"},{"key":"3429_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gie.2008.04.005","volume":"69","author":"WH Paik","year":"2009","unstructured":"Paik WH, Park YS, Hwang J-H, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc. 2009;69:55\u201362. https:\/\/doi.org\/10.1016\/j.gie.2008.04.005.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2468-1253(18)30234-6","volume":"3","author":"RJS Coelen","year":"2018","unstructured":"Coelen RJS, Roos E, Wiggers JK, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3:681\u201390. https:\/\/doi.org\/10.1016\/S2468-1253(18)30234-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3429_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.gie.2017.04.037","volume":"86","author":"TH Lee","year":"2017","unstructured":"Lee TH, Kim TH, Moon JH, et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817\u201327. https:\/\/doi.org\/10.1016\/j.gie.2017.04.037.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR26","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3748\/wjg.v13.i29.3948","volume":"13","author":"SH Lee","year":"2007","unstructured":"Lee SH, Park JK, Yoon WJ, et al. Optimal biliary drainage for inoperable Klatskin\u2019s tumor based on Bismuth type. World J Gastroenterol. 2007;13:3948\u201355. https:\/\/doi.org\/10.3748\/wjg.v13.i29.3948.","journal-title":"World J Gastroenterol"},{"key":"3429_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1067\/mge.2001.113381","volume":"53","author":"GD de Palma","year":"2001","unstructured":"de Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547\u201353. https:\/\/doi.org\/10.1067\/mge.2001.113381.","journal-title":"Gastrointest Endosc"},{"key":"3429_CR28","doi-asserted-by":"publisher","first-page":"E203","DOI":"10.1055\/a-0990-9114","volume":"8","author":"Y Ba","year":"2020","unstructured":"Ba Y, Yue P, Leung JW, et al. Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinoma. Endosc Int Open. 2020;8:E203\u201310. https:\/\/doi.org\/10.1055\/a-0990-9114.","journal-title":"Endosc Int Open"},{"key":"3429_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.gie.2021.03.021","volume":"94","author":"CJ Acosta","year":"2021","unstructured":"Acosta CJ, Goldberg D, Amin S. Evaluating the impact of frailty on periprocedural adverse events and mortality among patients with GI bleeding. Gastrointest Endosc. 2021;94:517\u2013e52511. https:\/\/doi.org\/10.1016\/j.gie.2021.03.021.","journal-title":"Gastrointest Endosc"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03429-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03429-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T08:15:21Z","timestamp":1728548121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03429-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3429"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03429-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4320025\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was submitted to the ethics board of the Hamburg chamber of physicians and was approved without a formal vote because of the retrospective nature of the study. Further, the need for informed consent was waived by the ethics board of the Hamburg chamber of physicians (reference numbers 2022-300198-WF, WF-078\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"External funding sources specific to this paper"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The study was registered in the German Clinical Trials Registry (DRKS) on 7th of August 2023 (Clinical trial number DRKS00032372).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"359"}}